Patents by Inventor Jill Gregory

Jill Gregory has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NAMPT Inhibitors for Cancer Therapy
    Publication number: 20180312525
    Abstract: The invention features compounds of Formula (I), Formula (I)-A and Formula (I)-B as disclosed herein, as well as methods of synthesis, therapy, diagnostics, and assays.
    Type: Application
    Filed: July 3, 2018
    Publication date: November 1, 2018
    Inventors: Paul Mason, Kara Carter, Alexandra Joseph, Yiding Hu, Jill Gregory, Zhong Zhao, Christopher Yee, Mohamud Mohamud, Yibin Xiang, Sanjay Danthi, Yinyin Huang, Andrew Papoulis
  • NAMPT inhibitors and methods
    Patent number: 10017523
    Abstract: The invention features compounds of Formula (I), Formula (I)-A and Formula (I)-B as disclosed herein, as well as methods of synthesis, therapy, diagnostics, and assays.
    Type: Grant
    Filed: May 22, 2015
    Date of Patent: July 10, 2018
    Assignee: Genzyme Corporation
    Inventors: Paul Mason, Kara Carter, Alexandra Joseph, Yiding Hu, Jill Gregory, Zhong Zhao, Christopher Yee, Mohamud Mohamud, Yibin Xiang, Sanjay Danthi, Yinyin Huang, Andrew Papoulis
  • NAMPT Inhibitors and Methods
    Publication number: 20170107231
    Abstract: The invention features compounds of Formula (I), Formula (I)-A and Formula (I)-B as disclosed herein, as well as methods of synthesis, therapy, diagnostics, and assays.
    Type: Application
    Filed: May 22, 2015
    Publication date: April 20, 2017
    Inventors: Paul Mason, Kara Carter, Alexandra Joseph, Yiding Hu, Jill Gregory, Zhong Zhao, Christopher Yee, Mohamud Mohamud, Yibin Xiang, Sanjay Danthi, Yinyin Huang, Andrew Papoulis
  • Tetrahydroisoquinoline derivatives for treating protein trafficking diseases
    Patent number: 7541466
    Abstract: Tetrahydroisoquinoline derivatives, pharmaceutical compositions comprising them and methods of treating disease are disclosed herein. The disclosed compounds are useful in the treatment and prevention of diseases mediated by chloride channel activity and/or protein trafficking, including, but not limited to, diseases associated with impaired mucociliary clearance such as cystic fibrosis, bronchitis, emphysema, and the like.
    Type: Grant
    Filed: December 7, 2004
    Date of Patent: June 2, 2009
    Assignee: Genzyme Corporation
    Inventors: Marko J. Pregel, Bradford H. Hirth, John L. Kane, Jr., Shuang Qiao, Jill Gregory, Lisa Cuff
  • Tetrahydroisoquinoline derivatives for treating protein trafficking diseases
    Publication number: 20050176761
    Abstract: Tetrhydroisoquinoline derivatives, pharmaceutical compositions comprising them and methods of treating disease are disclosed herein. The disclosed compounds are useful in the treatment and prevention of diseases mediated by chloride channel activity and/or protein trafficking, including, but not limited to, diseases associated with impaired mucociliary clearance such as cystic fibrosis, bronchitis, emphysema, and the like.
    Type: Application
    Filed: December 7, 2004
    Publication date: August 11, 2005
    Applicant: Genzyme Corporation
    Inventors: Marko Pregel, Bradford Hirth, John Kane, Shuang Qiao, Jill Gregory, Lisa Cuff